The approval specifically covers use in patients with PD experiencing motor fluctuations despite current medical therapy
Postharvest Biol Technol 45:110 Hager A, Holocher K (1994) Localization of the xanthophyll-cycle enzyme violaxanthin de-epoxidase within the thylakoid lumen and abolition of its mobility by a (light-dependent) pH decrease
The Ozempic vs Mounjaro comparison is therefore more accurately framed as: semaglutide (at diabetes doses, off-licence for weight loss) vs tirzepatide (licensed for weight management)
Diverso il ruolo della circonferenza vita: la sua riduzione nelle prime 20 settimane si associava a un rischio CV inferiore nei mesi successivi, in modo pi consistente rispetto al calo ponderale
Unaltra possibilit riguarda lazione di altri farmaci antidiabetici associati allaumento di peso (come insulina e glipizide)
After 72 weeks, about 33% of people on the 7.2 mg dose lost at least 25% of their body weight, compared to about 17% of those taking the 2.4 mg dose